MED Medifast Inc

Price (delayed)

$11.95

Market cap

$133.61M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.33

Enterprise value

$89.32M

?
Relative Growth: Rel. Growth: 0
Relative Strength: Rel. Strength: 36
Relative Valuation: Rel. Valuation: 44
Relative Profitability: Rel. Profitability: 25

® : Medifast is the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTA VIA®, which provides people with a simple, yet comprehensive approach to help ...

Highlights
The company's quick ratio rose by 16% YoY and by 2.3% QoQ
Medifast's debt has soared by 111% YoY and by 72% from the previous quarter
Medifast's gross profit has decreased by 38% YoY and by 10% from the previous quarter

Key stats

What are the main financial stats of MED

MED stock price

How has the Medifast stock price performed over time
Intraday
2.84%
1 week
4.46%
1 month
13.59%
1 year
-11.94%
YTD
11.89%
QTD
12.63%

Financial performance

How have Medifast's revenue and profit performed over time
Revenue
$316.93M
Gross profit
$219.45M
Operating income
-$19.51M
Net income
-$25.6M
Gross margin
69.2%
Net margin
-8.1%
Medifast's net margin has decreased by 40% from the previous quarter
Medifast's gross profit has decreased by 38% YoY and by 10% from the previous quarter
MED's revenue is down by 34% year-on-year and by 8% since the previous quarter
Medifast's operating margin has decreased by 32% QoQ

Price vs fundamentals

How does MED's price correlate with its fundamentals

Growth

What is Medifast's growth rate over time

Valuation

What is Medifast stock price valuation
P/E
N/A
P/B
0.68
P/S
0.42
EV/EBIT
N/A
EV/EBITDA
19.9
EV/Sales
0.28
The EPS has declined by 28% since the previous quarter
MED's P/B is 86% below its 5-year quarterly average of 4.7 but 13% above its last 4 quarters average of 0.6
The equity has contracted by 9% YoY
The P/S is 40% lower than the 5-year quarterly average of 0.7 but 40% higher than the last 4 quarters average of 0.3
MED's revenue is down by 34% year-on-year and by 8% since the previous quarter

Efficiency

How efficient is Medifast business performance
The return on sales has dropped by 91% since the previous quarter
The return on invested capital has dropped by 61% since the previous quarter
MED's ROE is down by 31% QoQ
The ROA has decreased by 30% from the previous quarter

Dividends

What is MED's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Medifast financials performed over time
Medifast's total liabilities has increased by 20% YoY and by 18% QoQ
The company's quick ratio rose by 16% YoY and by 2.3% QoQ
Medifast's debt is 86% less than its equity
Medifast's debt to equity has soared by 133% YoY and by 75% from the previous quarter
Medifast's debt has soared by 111% YoY and by 72% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.